CARGO Therapeutics Inc. C... (CRGX)
NASDAQ: CRGX
· Real-Time Price · USD
4.46
0.09 (2.06%)
At close: May 02, 2025, 12:23 PM
2.06% (1D)
| Bid | 4.41 |
| Market Cap | 205.39M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -167.5M |
| EPS (ttm) | -3.72 |
| PE Ratio (ttm) | -1.2 |
| Forward PE | -1.81 |
| Analyst | Hold |
| Ask | 4.5 |
| Volume | 42,405 |
| Avg. Volume (20D) | 814,004 |
| Open | 4.46 |
| Previous Close | 4.37 |
| Day's Range | 4.34 - 4.46 |
| 52-Week Range | 3.00 - 25.45 |
| Beta | 0.64 |
About CRGX
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cell...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 13, 2023
Employees 167
Stock Exchange NASDAQ
Ticker Symbol CRGX
Website https://cargo-tx.com
Analyst Forecast
According to 7 analyst ratings, the average rating for CRGX stock is "Hold." The 12-month stock price forecast is $4, which is a decrease of -10.31% from the latest price.
Stock Forecasts1 month ago
+9.21%
CARGO Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
-74.3%
Cargo Therapeutics shares are trading lower after five firms downgraded the stock and Jefferies cut its price target from $32 to $3.
